Anonymous
Guest
Anonymous
Guest
Heard this from a friend at Merck. Select marketing roles at Cubist exiting this week. DNAs in market access will be next, TC will be gone in April and the area sales directors will be gone shortly after that. RBD and CBM positions will be kept in place until asymmetrical deployments are finalized at year end. Following enhanced compliance training the Cubist name will be no longer and both acute care sales teams will be under Merck and JF until integration is completed in early 2016. Good luck to all those involved.